Pulmonology

Despite its accessibility and affordability, azithromycin does not positively affect patients with COVID-19, according to a new UK study.

The new kinoid vaccine has shown positive results in mice with human proteins, and the France-based team remain optimistic of human trials in the future.

Roughly 60% of participants in the SINUS-24 and SINUS-52 trials reported improvements in the severity of loss-of-taste.

Researchers in the UK recommend early detection and treatment of food allergy and sensitization to avoid complications in adulthood.

Dr. Jorge Maspero speaks of the complications of severe chronic rhinosinusitis with nasal polyps and how dupilumab could improve the daily struggles patients face.

Despite a global decrease in asthma deaths, researchers say the disease is particularly threatening to patients with atopic dermatitis.

Dr. Jorge Maspero speaks of the recent successes of the two newest trials, and what they could mean for the future of chronic rhinosinusitis management.

The new PDUFA date for the biologic has been scheduled for early 2022.

Research shows that detailed systems of care for infants suffering with BPD are integral in managing the national rate of infection.

Researchers found that different pets elicit different allergy responses in child participants.

An investigative team is skeptical on the involvement if autonomic nervous function in cases of idiopathic pulmonary fibrosis.

Investigators suggest symptoms in asthmatic patients are more severe, although it does not result in higher mortality rates.

A team of investigators stress the impact of the disease on patients as mortality rates grow worldwide.

The National Institutes of Health expert and research joins to discuss the evolving understanding of vaping devices and effects.

A new Polish study calls for greater focus on asthma and the link to delirium in older patients, who may face greater mortality risk.

A large number of nationwide infection rates in long-term care facilities are a product of seasonal influenza and RSV, according to a new study.

Elexacaftor/tezacaftor/ivacaftor and ivacaftor was previously approved for CF patients at least 12 years old.

An expert discussion on categorizing climate change and the impact it will have on health in communities across the globe.

An expert discussion on climate change and air pollution effects on communities, including increased COVID-19 rates.

The newest findings show the TSLP inhibitor is beneficial over 52 weeks in patients aged 12-80 years old.

Meredith McCormack, MD discusses consequences of high air pollution levels in the United States found in the 2021 American Lung Association State of the Air Report.

Climate change health experts Poune Saberi, MD, and Alan S. Greenglass, MD, join Lungcast for a timely discussion on environmental health issues.

Not all individuals with sarcoidosis need to be treated.

The 2021 annual report finds that Los Angeles remains the most polluted US city, while negative impacts of climate change and COVID-19 are both linked to increased pollution rates.

The monoclonal antibody was linked to significant improvements in endoscopic nasal polyp and nasal obstruction symptom visual analogue scale scores.